DOP048 Efficacy and safety of dose de-escalation from 50 mg to 25 mg QD of obefazimod maintenance treatment: Analysis of a subset of patients with moderately to severely active ulcerative colitis (UC) who have completed 2 years with 25mg QDSilvio Danese, Séverine Vermeire, Britta Siegmund et al.|Journal of Crohn s and Colitis|2025Cited by 0